Literature DB >> 21196075

Exosomes as biomarker treasure chests for prostate cancer.

Diederick Duijvesz1, Theo Luider, Chris H Bangma, Guido Jenster.   

Abstract

CONTEXT: Although progress has been made with regard to types of markers (protein, DNA, RNA, and metabolites) and implementation of improved technologies (mass spectrometry, arrays, and deep sequencing), the discovery of novel biomarkers for prostate cancer (PCa) in complex fluids, such as serum and urine, remains a challenge. Meanwhile, recent studies have reported that many cancer-derived proteins and RNAs are secreted through small vesicles known as exosomes.
OBJECTIVE: This narrative review describes recent progress in exosome research, focusing on the potential role of exosomes as novel biomarkers for PCa. The purpose of this review is to acquaint clinicians and researchers in the field of urology with the potential role of exosomes as biomarker treasure chests and with their clinical value. EVIDENCE ACQUISITION: Medline and Embase entries between 1966 and September 2010 were searched using the keywords exosomes, microvesicles, prostasomes, biomarkers, prostate cancer, and urology. Leading publications and articles constructively contributing to exosome research were selected for this review. EVIDENCE SYNTHESIS: Exosomes are small vesicles (50-100 nm) secreted by almost all tissues; they represent their tissue origin. Purification of prostate- and PCa-derived exosomes will allow us to profile exosomes, providing a promising source of protein and RNA biomarkers for PCa. This profiling will contribute to the discovery of novel markers for the early diagnosis and reliable prognosis of PCa.
CONCLUSIONS: Although the initial results are promising, further investigations are required to assess the clinical value of these exosomes in PCa.
Copyright © 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21196075     DOI: 10.1016/j.eururo.2010.12.031

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  113 in total

1.  Label-free in vitro prostate cancer cell detection via photonic-crystal biosensor.

Authors:  Frank DeLuna; XiaoFei Ding; Ismael Sagredo; Gilbert Bustamante; Lu-Zhe Sun; Jing Yong Ye
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2018-02-20

2.  Port-to-port delivery: Mobilization of toxic sphingolipids via extracellular vesicles.

Authors:  Giuseppe Scesa; Ana Lis Moyano; Ernesto R Bongarzone; Maria I Givogri
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

3.  Extracellular vesicles from osteosarcoma cell lines contain miRNAs associated with cell adhesion and apoptosis.

Authors:  Sofía Jerez; Héctor Araya; Daniel Hevia; Carlos E Irarrázaval; Roman Thaler; Andre J van Wijnen; Mario Galindo
Journal:  Gene       Date:  2019-06-06       Impact factor: 3.688

Review 4.  Biomarkers for the Management of Castration-Resistant Prostate Cancer: We Are Not There Yet.

Authors:  Daniel P Petrylak; E David Crawford
Journal:  Target Oncol       Date:  2017-08       Impact factor: 4.493

5.  Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.

Authors:  Roopa Thapar; Mark A Titus
Journal:  Curr Metabolomics       Date:  2014-04

Review 6.  The potential of exosomes in diagnosis and treatment of inborn errors of metabolism.

Authors:  Bas W M van Balkom; Jaap van Doorn; Nanda M Verhoeven-Duif; Marianne C Verhaar
Journal:  J Inherit Metab Dis       Date:  2014-02-08       Impact factor: 4.982

7.  Quantitative and stoichiometric analysis of the microRNA content of exosomes.

Authors:  John R Chevillet; Qing Kang; Ingrid K Ruf; Hilary A Briggs; Lucia N Vojtech; Sean M Hughes; Heather H Cheng; Jason D Arroyo; Emily K Meredith; Emily N Gallichotte; Era L Pogosova-Agadjanyan; Colm Morrissey; Derek L Stirewalt; Florian Hladik; Evan Y Yu; Celestia S Higano; Muneesh Tewari
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

8.  BRN4 Is a Novel Driver of Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer and Is Selectively Released in Extracellular Vesicles with BRN2.

Authors:  Divya Bhagirath; Thao Ly Yang; Z Laura Tabatabai; Shahana Majid; Rajvir Dahiya; Yuichiro Tanaka; Sharanjot Saini
Journal:  Clin Cancer Res       Date:  2019-08-01       Impact factor: 12.531

9.  In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.

Authors:  Simona Principe; E Ellen Jones; Yunee Kim; Ankit Sinha; Julius O Nyalwidhe; Jasmin Brooks; O John Semmes; Dean A Troyer; Raymond S Lance; Thomas Kislinger; Richard R Drake
Journal:  Proteomics       Date:  2013-04-23       Impact factor: 3.984

Review 10.  Nuclear magnetic resonance spectroscopy as a new approach for improvement of early diagnosis and risk stratification of prostate cancer.

Authors:  Bo Yang; Guo-Qiang Liao; Xiao-Fei Wen; Wei-Hua Chen; Sheng Cheng; Jens-Uwe Stolzenburg; Roman Ganzer; Jochen Neuhaus
Journal:  J Zhejiang Univ Sci B       Date:  2017 Nov.       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.